Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Seres Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −4 vs. Q4 2023
- Shares held
- 85.8M
- −3.74M (−4.2%) vs. Q4 2023
- Total value
- $66.3M
- −$59.1M (−47.1%) vs. Q4 2023
- New holders
- 21
- 28 more added
- Sold out
- 25
- 28 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $17.9M |
| Q1 2026 | 33 | $20.5M |
| Q4 2025 | 36 | $36.4M |
| Q3 2025 | 32 | $40.9M |
| Q2 2025 | 33 | $25.4M |
| Q1 2025 | 63 | $43.1M |
| Q4 2024 | 69 | $52.5M |
| Q3 2024 | 77 | $60.1M |
| Q2 2024 | 93 | $50.0M |
| Q1 2024 | 99 | $66.3M |
| Q4 2023 | 103 | $125.4M |
| Q3 2023 | 134 | $255.6M |
| Q2 2023 | 138 | $538.1M |
| Q1 2023 | 123 | $593.9M |
| Q4 2022 | 124 | $588.2M |
| Q3 2022 | 120 | $671.6M |
| Q2 2022 | 123 | $312.7M |
| Q1 2022 | 131 | $537.2M |
| Q4 2021 | 148 | $642.8M |
| Q3 2021 | 133 | $555.1M |
| Q2 2021 | 147 | $1.93B |
| Q1 2021 | 154 | $1.85B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −817,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −640,655−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −393,760−100.0% | Sold out |
| Knott David M Jr | 0 | $0 | 0.00% | −370,730−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −349,588−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −324,209−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −114,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −100,812−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −71,523−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −60,749−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −55,011−100.0% | Sold out |
| Edgewood Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −43,163−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −39,948−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −39,004−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −24,700−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −24,600−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −20,440−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −18,639−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −15,304−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −10,016−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −5,750−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −2,856−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |